205 related articles for article (PubMed ID: 7586607)
1. High prevalence of nodular thyroid disease in patients with Cushing's disease.
Invitti C; Manfrini R; Romanini BM; Cavagnini F
Clin Endocrinol (Oxf); 1995 Sep; 43(3):359-63. PubMed ID: 7586607
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease.
Colao A; Pivonello R; Faggiano A; Filippella M; Ferone D; Di Somma C; Cerbone G; Marzullo P; Fenzi G; Lombardi G
Clin Endocrinol (Oxf); 2000 Jul; 53(1):13-9. PubMed ID: 10931076
[TBL] [Abstract][Full Text] [Related]
3. [Pituitary-thyroid function in patients with Cushing's syndrome--comparative study before and after extirpation of adrenal cortex tumor].
Kitahara H; Imai Y; Yamauchi K; Tomita A; Mizuno S
Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1086-98. PubMed ID: 6420208
[TBL] [Abstract][Full Text] [Related]
4. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
5. The nocturnal serum thyrotropin surge is abolished in patients with adrenocorticotropin (ACTH)-dependent or ACTH-independent Cushing's syndrome.
Bartalena L; Martino E; Petrini L; Velluzzi F; Loviselli A; Grasso L; Mammoli C; Pinchera A
J Clin Endocrinol Metab; 1991 Jun; 72(6):1195-9. PubMed ID: 1851180
[TBL] [Abstract][Full Text] [Related]
6. PRKAR1A-negative familial Cushing's syndrome: two case reports.
Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone status following treatment for Cushing's syndrome.
Hughes NR; Lissett CA; Shalet SM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
[TBL] [Abstract][Full Text] [Related]
8. Primary thyroid disorders in endogenous Cushing's syndrome.
Niepomniszcze H; Pitoia F; Katz SB; Chervin R; Bruno OD
Eur J Endocrinol; 2002 Sep; 147(3):305-11. PubMed ID: 12213667
[TBL] [Abstract][Full Text] [Related]
9. Thyroid axis in patients with Cushing's syndrome.
Duick DS; Wahner HW
Arch Intern Med; 1979 Jul; 139(7):767-72. PubMed ID: 110278
[TBL] [Abstract][Full Text] [Related]
10. Thyroid function spectrum in Cushing's syndrome.
Yu P; Yuan H; Chen H; Li X
BMC Endocr Disord; 2024 Jun; 24(1):80. PubMed ID: 38840128
[TBL] [Abstract][Full Text] [Related]
11. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of fluctuations in thyroid hormones after surgery for Cushing's syndrome.
Tamada D; Kitamura T; Onodera T; Hamasaki T; Otsuki M; Shimomura I
Endocr J; 2015; 62(9):805-10. PubMed ID: 26156592
[TBL] [Abstract][Full Text] [Related]
13. A study of thyroid functions in patients with Cushing's syndrome: a single-center experience.
Xiang B; Tao R; Liu X; Zhu X; He M; Ma Z; Yang Y; Zhang Z; Li Y; Yao Z; Wang Y; Ye H
Endocr Connect; 2019 Aug; 8(8):1176-1185. PubMed ID: 31336363
[TBL] [Abstract][Full Text] [Related]
14. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma.
Takasu N; Komiya I; Nagasawa Y; Asawa T; Yamada T
N Engl J Med; 1990 Jun; 322(24):1708-12. PubMed ID: 2342537
[TBL] [Abstract][Full Text] [Related]
17. TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome'.
Benker G; Raida M; Olbricht T; Wagner R; Reinhardt W; Reinwein D
Clin Endocrinol (Oxf); 1990 Dec; 33(6):777-86. PubMed ID: 2128925
[TBL] [Abstract][Full Text] [Related]
18. Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's.
Hirsch D; Shimon I; Manisterski Y; Aviran-Barak N; Amitai O; Nadler V; Alboim S; Kopel V; Tsvetov G
Endocrine; 2018 Dec; 62(3):712-720. PubMed ID: 30084101
[TBL] [Abstract][Full Text] [Related]
19. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
20. Plasma testosterone profiles in Cushing's syndrome.
Smals AG; Kloppenborg PW; Benraad TJ
J Clin Endocrinol Metab; 1977 Aug; 45(2):240-5. PubMed ID: 195973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
